Depending on the application, MicroGuard antimicrobial copper alloys may contribute to earning LEED credits as part of the U.S. Green Building Council's Leadership in Energy and Environmental Design certification program. For healthcare and other commercial buildings focused on sustainable design practices, MicroGuard antimicrobial copper materials provide benefits throughout the entire life cycle of the product.
The life cycle cost alone can make MicroGuard materials economical for commercial buildings. Initial cost, maintenance, and the life expectancy of the product must be evaluated as well as the salvage value of the metal. MicroGuard antimicrobial copper alloys are 100% recyclable while retaining most of the primary metal value.
In addition, MicroGuard touch surfaces kill 99.9% of infectious bacteria* including MRSA within two hours when cleaned regularly. Safe to use and effective, MicroGuard is the first solid surface material to be registered by the EPA with a public health claim. MicroGuard continuously reduces microbial burden* in between routine cleaning.
For sustainable buildings with antimicrobial touch surfaces, only MicroGuard copper can offer all of these benefits:
- Recycled content of up to 100%
- Can be produced with renewable wind energy of up to 100% for electric
- Produces no landfill waste during manufacturing and fabrication
- Can be shipped with recyclable or biodegradable packaging
- Shipped from a plant located in the Midwest
- Available in coil, strip, sheet, plate, and tube forms
- Attractive finishes and textures available
- EPA registered with a public health claim
- Kills 99.9% of bacteria* within two hours of exposure
- Safe to use
Economical, when compared to other building materials, maintenance-free and long-lasting, MicroGuard antimicrobial copper alloys are an excellent value for touch surfaces in high performance buildings.
*Testing demonstrates effective antibacterial activity against Staphylococcus aureus, Enterobacter aerogenes, Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli O157:H7, Pseudomonas aeruginosa, and Vancomycin-resistant Enterococcus faecalis (VRE).